A peculiar sequence motif in the alpha-1-domain of the HLA-C molecule in psoriasis

Dermatology

Volumn 200, Issue 2, 2000, Pages 99-103

  Brazzelli, V ^a   Quaglini, M ^a   Martinetti, M ^b   Nolli, G ^a   Salvaneschi, L ^b   Cuccia, M ^d   Borroni, Giovanni ^a,c  

^a Institute of Dermatology   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d NONE

Author keywords

HLA C sequence motif; Psoriasis; 1 domain

Indexed keywords

ALANINE; ASPARAGINE; ASPARTIC ACID; HLA C ANTIGEN; LYSINE;

ADULT; AGED; ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENOME; HOMOZYGOSITY; HUMAN; ITALY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS;

EID: 0034037768     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018338     Document Type: Article

References (22)

1. Greaves MW, Weinstein GD: Treatment of psoriasis. N Engl J Med 1995;332:581-588.
2. Elder JT, Nair RP, Voorhees JJ: Epidemiology and the genetics of psoriasis. J Invest Dermatol 1994;102:24S-28S.
3. Trowsdale J, Ragoussis J, Champbell RD: Map of the human MHC. Immunol Today 1991;12: 443-446.
4. Ikaheimo I, Silvennoinen-Kassinen S, Karvonen J, Jarvinen T, Tilikainen A: Immunogenetic profile of psoriasis vulgaris: Association with haplotypcs A2, B13, Cw6, DR7, DQA1*0201 and A1, B17, Cw6, DR7, DQA1*0201. Arch Dermatol Res 1996;288:63-67.
5. Russel TJ, Schultes LM, Kuban DJ: Histocompatibility (HLA) antigens associated with psoriasis. N Engl J Med 1972;287:738-740.
6. Schmitt-Egenolf M, Boehncke WH, Stander M, Eiermann TH: Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2. DQA1*0201, DQB1*0303 extended haplotype. J Invest Dermatol 1993;100: 749-752.
7. Schmitt-Egenolf, Eiermann TH, Boehncke WH, Stander M, Sterry W: Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) Class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: A population and family-based study. J Invest Dermatol 1996; 106:711-714.
8. Ikaheimo I, Silvennoinen-Kassinen S, Karvonen J, Tilikainen A: Alanine at position 73 of HLA-C is associated with psoriasis vulgaris in Finland. Br J Dermatol 1994;131:257-259.
9. Olerup O, Zetterquist H: HLA-DR typing in clinical practice including donor recipient matching in cadaveric transplantations. Tissue Antigens 1992;39:225-235.
10. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16:1215.
11. Mallon E, Bunce M, Wojnarowska F, Welsh K: HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence ALA-73 is increased in male type I psoriatics. J Invest Dermatol 1997;109:183-186.
12. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, Barker JN: Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997;6:813-820.
13. Jenisch S, Henseler T, Nair RP, Guo SW, Westphal E, Stuart P, Kronke M, Voorhees JJ, Christophers E, Elder JT: Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: Strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 1998; 63:191-199.
14. Leder RO, Mansbridge JN, Hallmayer J, Hodge SE: Familial psoriasis and HLA-B: Unambiguous support for linkage in 97 published families. Hum Hered 1998;48:198-211.
15. Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC: Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989;342:692-696.
16. Saper MA, Bjorkman PJ, Wiley DC: Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 1991;219:277-319.
17. Matsumura M, Fremont DH, Peterson PA, Wilson IA: Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992;257:927-934.
18. Chelvanayagam G: A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 1996;45:15-26.
19. Bjorkman PJ, Saper MA, Samraoui B, Bennet WS, Strominger JL, Wiley DC: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-518.
20. Bjorkman PJ, Saper MA, Samraoui B, Bennet WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506-512.
21. Mandelboim O, Reyburn HT, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G, Strominger JL: Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility complex molecules. J Exp Med 1996;184: 913-922.
22. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F: Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med 1994;180:2353-2358.